Would you like to contribute to this site?
Arthritis Menu
Submit an Article
Submit a Tip
Place your Ad
Add URL
Arthritis Questions?
Contact Us
Related Topics:
Rheumatoid Arthritis
Rheumatoid Arthritis Complication
Rheumatoid Arthritis Cure
Rheumatoid Arthritis Diagnosis
Rheumatoid Arthritis Disability
Rheumatoid Arthritis Eyes
Rheumatoid Arthritis Knee
Rheumatoid Arthritis Nodules
Rheumatoid Arthritis Nutrition
Rheumatoid Arthritis Pregnancy
Rheumatoid Arthritis Prevention
Rheumatoid Arthritis Prognosis
Rheumatoid Arthritis Test
Type Of Rheumatoid Arthritis
People With Rheumatoid Arthritis
Rheumatoid Arthiritis
Rheumatoid Arthritis Hand
Rheumatoid Arthritis Info
Rheumatoid Arthritis Treatment
Cure For Rheumatoid Arthritis
Rheumetoid Arthritis
Other Channels:
|
 |
|
|
|
|
|
|
|
|
Recent Questions and Answers
|
|
|
|
|
|
|
|
Recent People With Rheumatoid Arthritis News:
|
|
|
NEW YORK (December 20, 2011)—Drug-maker Pfizer Inc. said Tuesday the U.S. Food and Drug Administration has accepted its application for approval of its experimental drug for adults with moderate to severe rheumatoid arthritis. The FDA said it expects to ...
Pfizer announced that the FDA has accepted for review its New Drug Application (NDA) for tofacitinib for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA). The NDA is based on previously completed Phase 3 trials ...
U.S. health regulators have accepted the application for Pfizer Inc's closely watched experimental rheumatoid arthritis drug, the drugmaker said on Tuesday. The Food and Drug Administration is due to decide on the drug, tofacitinib, in August. Pfizer said ...
An intervention aimed at helping patients accept the pain and disability associated with rheumatoid arthritis, while at the same time blocking negative thoughts and anxiety about their condition, reduced patients' depression and improved coping skills ...
| |
| |
|
|
|
Additional People With Rheumatoid Arthritis Resources:
|
|
|
|
|
|
|
|
|
Want your site featured on this page?
|
|
 |
|